Kinney Gene G. (CIK 0001564380)

Latest company ownership

Shares held
152,793
Last filed at
Jul 30, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 17, 2023 May 17, 2023 PROTHENA CORP PUBLIC LTD CO CEO Sell 5.0 -45,000 -77.86% ✓ $3.3M
Sep 28, 2022 Sep 30, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 7.5 -16,412 -56.20% ✓ $876K
Sep 21, 2022 Sep 23, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 20.0 -2,720 -17.53% ✓ $87.1K
Aug 17, 2022 Aug 19, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 25.0 -2,181 -14.57% ✓ $69.9K
Aug 10, 2022 Aug 12, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 5.0 -34,925 -47.64% ✓ $1.1M
Aug 4, 2022 Aug 5, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 5.0 -42,460 -49.65% ✓ $1.4M
Jul 27, 2022 Jul 29, 2022 PROTHENA CORP PUBLIC LTD CO CEO Sell 45.0 -376 -2.86% ✓ $12K
Sep 28, 2017 Sep 29, 2017 PROTHENA CORP PUBLIC LTD CO CEO Sell 22.5 -2,800 -50.06% ✗ $196K
Mar 1, 2017 Mar 3, 2017 PROTHENA CORP PUBLIC LTD CO CEO Sell 17.5 -25,163 -90.01% ✗ $1.5M
Feb 28, 2017 Mar 2, 2017 PROTHENA CORP PUBLIC LTD CO CEO Sell 22.5 -3,796 -57.61% ✗ $227.8K
Nov 9, 2016 Nov 10, 2016 PROTHENA CORP PUBLIC LTD CO CEO Sell 20.0 -8,548 -75.37% ✗ $472.9K
Oct 20, 2016 Oct 21, 2016 PROTHENA CORP PUBLIC LTD CO CEO Sell 5.0 -20,619 -78.68% ✓ $1.1M
Dec 9, 2015 Dec 11, 2015 PROTHENA CORP PUBLIC LTD CO CSO & Head of R&D Sell 17.5 -30,000 -91.48% ✗ $2M
May 9, 2014 May 12, 2014 PROTHENA CORP PUBLIC LTD CO CSO & Head of R&D Buy 91.3 +2,500 853.24% ✗ $48.8K